Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Mo-Rez
Female Reproductive System Neoplasm
GlaxoSmithKline
P1/2
CCC
(48)
MP0533
Acute Disease
Molecular Partners AG
P1/2
CCC
(48)
MP0533
Myeloid Neoplasm
Molecular Partners AG
P1/2
CCC
(48)
Mrt-2359
Neuroendocrine Carcinoma
Monte Rosa Therapeutics, Inc
P1/2
CCC
(48)
mt-101
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Myeloid Therapeutics
P1/2
CCC
(48)
mt-101
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Myeloid Therapeutics
P1/2
CCC
(48)
mt-4561
Neuroendocrine Neoplasm
Tanabe Pharma America, Inc.
P1/2
CCC
(48)
Mtp-101C
Amyotrophic Lateral Sclerosis
Duke University
P1/2
CCC
(48)
Mva-209-Fsp, Rp2D
Lynch Syndrome
National Cancer Institute (NCI)
P1/2
CCC
(48)
Mva-Magea3
Esophageal Squamous Cell Carcinoma
Cancer Research UK
P1/2
CCC
(48)
Mva-Nyeso
Esophageal Squamous Cell Carcinoma
Cancer Research UK
P1/2
CCC
(48)
n17350
Triple-Negative Breast Carcinoma
Onchilles Pharma Inc
P1/2
CCC
(48)
n17350
Squamous Cell Carcinoma
Onchilles Pharma Inc
P1/2
CCC
(48)
n17350
Skin Squamous Cell Carcinoma
Onchilles Pharma Inc
P1/2
CCC
(48)
Naltrexone
Inflammatory Disease
Truway Health, Inc.
P1/2
CCC
(48)
Naltrexone
Systemic Lupus Erythematosus
Truway Health, Inc.
P1/2
CCC
(48)
Narazaciclib
Plasma Cell Myeloma
Adriana Rossi
P1/2
CCC
(48)
Navitoclax
Acute Lymphoblastic Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CCC
(48)
Naxitamab
Triple-Negative Breast Carcinoma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Nbm-Bmx
Ocular Cancer
Novelwise Pharmaceutical Corporation
P1/2
CCC
(48)
Nelfinavir
Prostate Cancer
Medical University of South Carolina
P1/2
CCC
(48)
neo212
Metastatic Malignant Neoplasm In The Brain
Neonc Technologies, Inc.
P1/2
CCC
(48)
Neoantigen Specific Tcr-T Cell Drug Product
Lung Adenocarcinoma
Alaunos Therapeutics
P1/2
CCC
(48)
Neoantigen Specific Tcr-T Cell Drug Product
Adenosquamous Lung Carcinoma
Alaunos Therapeutics
P1/2
CCC
(48)
Neoantigen Specific Tcr-T Cell Drug Product
Ovarian Neoplasm
Alaunos Therapeutics
P1/2
CCC
(48)
Showing 1501 to 1525 of 6,308 assets
Previous
Page 61 of 253
Next